03.11.2012 Views

Bausch & Lomb 1999 Annual Report

Bausch & Lomb 1999 Annual Report

Bausch & Lomb 1999 Annual Report

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Corporate Information<br />

Internet Address:<br />

Corporate, product, financial and shareholder information,<br />

including news releases, financial filings and stock quotes are<br />

available at <strong>Bausch</strong> & <strong>Lomb</strong>’s web site:<br />

www.bausch.com<br />

Corporate Headquarters:<br />

One <strong>Bausch</strong> & <strong>Lomb</strong> Place<br />

Rochester, New York 14604<br />

(716) 338-6000<br />

(800) 344-8815<br />

News on Demand:<br />

<strong>Bausch</strong> & <strong>Lomb</strong>’s news releases are available toll-free by calling:<br />

(888) 329-1096<br />

Financial Literature:<br />

Copies of <strong>Bausch</strong> & <strong>Lomb</strong>’s annual reports and financial reports filed<br />

with the Securities and Exchange Commission, including its Form<br />

10-K, are available on our website, by mail (attn: Investor Relations)<br />

or by calling:<br />

(888) 884-8702<br />

(716) 338-5757<br />

Investor Relations:<br />

Security analysts and shareholders seeking information concerning<br />

company operations, shareholder programs or dividend policy<br />

may contact:<br />

Angela J. Panzarella<br />

Vice President, Investor Relations<br />

(716) 338-6025<br />

Angela_J_Panzarella@bausch.com<br />

Media Inquiries:<br />

News media representatives and others seeking general information<br />

may contact:<br />

Holly Houston<br />

Director, Media Relations<br />

(716) 338-8064<br />

Holly_Houston@bausch.com<br />

Transfer Agent:<br />

Shareholders seeking information regarding their individual accounts<br />

or dividend payments may contact our stock transfer agent:<br />

ChaseMellon Shareholder Services<br />

P.O. Box 3315<br />

South Hackensack, New Jersey 07606<br />

(800) 288-9541<br />

www.chasemellon.com<br />

Total recycled fiber content of not less than 50%<br />

Dividend Reinvestment Plan:<br />

The plan is available to all shareholders of <strong>Bausch</strong> & <strong>Lomb</strong> stock.<br />

Under the plan, shareholders may elect to have their cash dividends<br />

automatically invested in additional shares of the company’s common<br />

stock. Shareholders may also elect to make cash contributions of up<br />

to $60,000 per year to purchase additional shares. For additional<br />

information contact:<br />

Mellon Bank, N.A.<br />

Investment Services<br />

P.O. Box 3339<br />

South Hackensack, New Jersey 07606<br />

(800) 288-9541<br />

www.chasemellon.com<br />

Stock Listing:<br />

The common stock of the corporation is traded under the symbol<br />

BOL on the New York Stock Exchange. Options on the company’s<br />

common stock are traded on the American Stock Exchange.<br />

Trademarks:<br />

The trademarks of <strong>Bausch</strong> & <strong>Lomb</strong> Incorporated and its subsidiary<br />

companies referred to in this report are:<br />

Aberrometer<br />

Alrex<br />

AMVISC<br />

AMVISC Plus<br />

<strong>Bausch</strong> & <strong>Lomb</strong><br />

Boston<br />

Boston EO<br />

Catarex<br />

Hansatome<br />

Design: Richard Uccello, Andrew Wessels<br />

Ted Bertz Graphic Design<br />

Middletown, Connecticut<br />

Printing: Finlay Brothers Printing<br />

Bloomfield, Connecticut<br />

Executive Portrait: Ted Kawalerski<br />

New York, New York<br />

©2000 <strong>Bausch</strong> & <strong>Lomb</strong> Incorporated<br />

All Rights Reserved Worldwide<br />

Medalist<br />

Millennium<br />

MPORT<br />

MPORT SI<br />

Ocuvite<br />

Ocuvite Extra<br />

Opcon-A<br />

Orbscan<br />

Orbscan II<br />

Passport<br />

PureVision<br />

ReNu<br />

ReNu MultiPlus<br />

SofLens<br />

SofLens66<br />

Soflex<br />

Technolas 217<br />

Vitrasert<br />

EVA is a trademark of Stern Stewart & Co.<br />

Lotemax is a trademark of Pharmos Corporation<br />

Polytrim is a trademark of Allergan, Inc.<br />

Surodex is a trademark of Oculex Pharmaceuticals, Inc.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!